CME Quiz

AAFP members and other physicians and health care professionals who
receive the print version of AFP in their own name can submit responses for
CME credit at https://​w ww.aafp.org/afpquiz. Quiz questions are featured below
for your convenience. This issue is approved for up to 7 Prescribed and AMA PRA
Category 1 credits. The total credit for this issue is based on one credit for each
article included in the Quiz. Credits may be claimed for one year from the date
of this issue. Questions? Call 800-274-2237.

Amblyopia:​Detection and Treatment (p. 745)
Q1. Which one of the following statements about testing
for amblyopia is correct? (check one)
l A. An occluder is preferable to an eye patch when
performing visual acuity tests.
l B. Vision screening should be done once between
four and six years of age.
l C. Visual acuity of less than 20/40 in either eye of a
child three to five years of age is abnormal.
l D. Photoscreening devices are limited by their inabil-
ity to capture the red reflex.
Q2. A five-year-old child with eye deviation is found
to have moderate amblyopia. Which one of the follow
statements about the treatment of this patient is correct?
(check one)
l A. Because of the child’s age, treatment will likely be
ineffective.
l B. Patching the eye is superior to other treatments.
l C. If treatment is successful, monitoring is no longer
required.
l D. Atropine 1% ophthalmic drops can be effective
when given on two consecutive days per week.
Q4. For which one of the following age ranges is an
annual influenza vaccination recommended? (check one)
l A. Adults 18 to 65 years.
l B. Children younger than five years and adults 65
years and older.
l C. All people six months and older who do not have
contraindications.
l D. All people two years and older.
Cirrhosis:​Diagnosis and Management (p. 759)
Q5. Which one of the following statements about the
progression of chronic liver disease to cirrhosis is correct?
(check one)
l A. All patients with chronic liver disease will progress
to cirrhosis within 20 years.
l B. Men with chronic liver disease are more likely to
progress to cirrhosis than women, regardless of
the underlying etiology.
l C. Younger patients with chronic liver disease have a
greater risk of progression to cirrhosis.
l D. Coinfection with HIV and hepatitis C virus sig-
nificantly increases the risk of progression to
cirrhosis.

Influenza:​Diagnosis and Treatment (p. 751)
Q3. Which one of the following statements about the
treatment of influenza is correct? (check one)
l A. Treatment within 24 hours of symptom onset
results in a reduction in symptom duration of
approximately one day.
l B. Treatment within 48 hours of symptom onset
results in a reduction in symptom duration of
approximately one day.
l C. Treatment within 72 hours of symptom onset
results in a reduction in symptom duration of
approximately one day.
l D. Treatment within 96 hours of symptom onset
results in a reduction in symptom duration of
approximately one day.
Q6. A 54-year-old woman presents with multiple medical
problems, including cirrhosis secondary to chronic hep-
atitis B infection. Which one of the following recommen-
dations for this patient is correct? (check one)
l A. She should stop taking her metformin and begin
taking insulin, regardless of her A1C level.
l B. Statins are contraindicated.
l C. She should have right upper quadrant ultrasonog-
raphy every six months.
l D. She should get a 23-valent pneumococcal poly-
saccharide vaccine (Pneumovax 23) once she
turns 65.

738 American
Downloaded Family
from the AmericanPhysician
Family Physician website at www.aafp.org/afp. Copyright © 2019 American Academy
www.aafp.org/afp Volumeof Family Physicians.
100, Number 12 For the private,15,
◆ December noncom-
mercial use of one individual user of the website. All other rights reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.
2019

Downloaded for Ahmed Hemaid (aihmaid@seha.ae) at Abu Dhabi Health Services Co from ClinicalKey.com by Elsevier on
September 16, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.
 CME QUIZ

Q7. Which one of the following statements about tran- Point-of-Care Guides
sient elastography is correct? (check one) Diagnosing DVT in Nonpregnant Adults
l A. It is more accurate than biomarker-based scoring in the Primary Care Setting (p. 778)
tools at ruling out cirrhosis.
Q10. Which one of the following statements about the
l B. One drawback is that it takes 90 minutes to Wells score for evaluating the risk of deep venous throm-
perform. bosis (DVT) is correct? (check one)
l C. It is more accurate in patients with obesity. l A. It uses a subjective judgment question, which is a
l D. It is more accurate if performed during an epi- potential limitation.
sode of acute hepatic inflammation. l B. It is more accurate in older patients than in
younger patients.
l C. It is more accurate for recurrent than for initial
Lown Right Care:​Reducing Overuse and Underuse DVT.
Overuse of Statins in Older Adults (p. 742) l D. It is more accurate than the Dutch Primary Care
Q8. Which one of the following statements about statins Rule for ruling out DVT.
is correct? (check one)
l A. The most commonly reported adverse effect is
fatigue. Practice Guidelines
l B. Statins slightly decrease the risk of developing Managing Chronic Hypertension
diabetes mellitus. in Pregnant Women:​ACOG Releases
l C. The U.S. Preventive Services Task Force states that Updated Practice Bulletin (p. 782)
current evidence is insufficient to assess the bal- Q11. According to the American College of Obstetricians
ance of benefits and harms of statins for primary and Gynecologists (ACOG), which one of the following
prevention for persons older than 75 years. is the recommended blood pressure treatment goal for
l D. There has been a decrease in people older than pregnant patients with chronic hypertension? (check one)
65 years taking statins for primary prevention of l A. 110 to 120 mm Hg systolic and 75 to 84 mm Hg
cardiovascular disease since 2012. diastolic.
l B. 120 to 130 mm Hg systolic and 80 to 89 mm Hg
diastolic.
Putting Prevention into Practice
l C. 120 to 139 mm Hg systolic and 80 to 99 mm Hg
Screening for Pancreatic Cancer (p. 771) diastolic.
Q9. Which one of the following statements represents l D. 120 to 159 mm Hg systolic and 80 to 109 mm Hg
the U.S. Preventive Services Task Force (USPSTF) findings diastolic.
regarding the potential benefits and harms of screening
for pancreatic cancer? (check one)
l A. The USPSTF found adequate evidence that
screening for pancreatic cancer improves
disease-specific morbidity but not all-cause
mortality.
l B. The USPSTF found adequate evidence that the
harms of treating pancreatic cancer are small.
l C. The USPSTF found insufficient evidence to assess
the benefits and harms of screening for pancre-
atic cancer.
l D. The USPSTF found no evidence that screening
for pancreatic cancer improves disease-specific
morbidity or mortality.
l E. Based on the increasing incidence of pancreatic
cancer, the USPSTF found convincing evidence
that the potential benefits of screening outweigh
the harms.

Answers to this issue’s quiz are on the inside back cover.

December 15, 2019 ◆ Volume 100, Number 12 www.aafp.org/afp American Family Physician 739

Downloaded for Ahmed Hemaid (aihmaid@seha.ae) at Abu Dhabi Health Services Co from ClinicalKey.com by Elsevier on
September 16, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.
 Advertiser Index
What do
AAFP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 736*, 741*, 781*

AAFP Audio/AAFP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 744

you know?
AFP Photo Quiz App/AAFP . . . . . . . . . . . . . . . . . . . . . . . . 3rd Cover

AFP Podcast/AAFP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 772

Cologuard/PFIZER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 781*

Descovy/GILEAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2nd Cover

ESPERION THERAPEUTICS, INC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 775

MiraLAX/BAYER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 733

NEW YORK STATE DEPARTMENT OF HEALTH . . . . . . . . . . . . . . . . . . . . 736*

REDHILL BIOPHARMA, INC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4th Cover

Xofluza/GENENTECH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 740A*

*DOES NOT APPEAR IN ALL COPIES.

Answers to This Issue’s CME Quiz

Q1. C Q4. C Q7. A Q10. A
Q2. D Q5. D Q8. C Q11. D
Q3. A Q6. C Q9. D

Find out.
Download the
AMERICAN FAMILY PHYSICIAN ®
AFP Photo Quiz app.

AMERICAN FAMILY PHYSICIAN ®

AMERICAN FAMILY PHYSICIAN ®

Downloaded for Ahmed Hemaid (aihmaid@seha.ae) at Abu Dhabi Health Services Co from ClinicalKey.com by Elsevier on ®
September 16, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.